SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-004931
Filing Date
2019-04-29
Accepted
2019-04-29 16:16:52
Documents
62
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrtx-20190331x10q.htm 10-Q 887158
2 EXHIBIT 5.1 ex51opinionofcooleyllp.htm EX-5.1 13546
3 EXHIBIT 10.1 ex101bmsmirati.htm EX-10.1 419346
4 EXHIBIT 10.2 ex102miratiarrayddcoa.htm EX-10.2 388797
5 EXHIBIT 31.1 mrtx033119ex311.htm EX-31.1 12407
6 EXHIBIT 31.2 mrtx033119ex312.htm EX-31.2 12871
7 EXHIBIT 32.1 mrtx033119ex321.htm EX-32.1 8232
14 bmsandmiratictcsaands_image1.jpg GRAPHIC 60432
  Complete submission text file 0001628280-19-004931.txt   4696304

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT mrtx-20190331.xml EX-101.INS 745802
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrtx-20190331.xsd EX-101.SCH 29956
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrtx-20190331_cal.xml EX-101.CAL 47709
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrtx-20190331_def.xml EX-101.DEF 108185
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrtx-20190331_lab.xml EX-101.LAB 358174
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrtx-20190331_pre.xml EX-101.PRE 202961
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35921 | Film No.: 19776105
SIC: 2834 Pharmaceutical Preparations